The World Health Organization (WHO) has confirmed that it will maintain its highest alert level for mpox, an infectious disease that has seen a troubling rise in cases in various regions, particularly in Central Africa. This decision was reached during a recent meeting of WHO officials and independent experts in Geneva, three months after the agency initially declared a public health emergency of global concern in August.
According to the WHO, this alert is warranted due to the increasing number of mpox infections and their continuing geographic spread. Operational challenges on the ground and the necessity for a unified response among countries have also contributed to this decision. The rise in cases has primarily affected the Democratic Republic of the Congo (DRC) and its neighboring countries, highlighting the need for immediate and coordinated public health measures.
In response to the escalating crisis, a preliminary batch of vaccines was administered in the region last month. Although early data suggest that vaccinations may help curb the spread of this highly contagious disease, the WHO is keenly awaiting more comprehensive evidence to evaluate the effectiveness of the vaccination campaign fully.
The African Union’s health agency recently cautioned that the mpox outbreak remains a significant concern, calling for increased resources and proactive measures to prevent a potential pandemic that experts warn could rival the scale of the COVID-19 crisis. While mpox is generally characterized by mild symptoms, there are rare cases where it can be fatal, underscoring the importance of vigilance and preparedness.
Last year, the disease claimed hundreds of lives in the DRC and spread to neighboring countries including Burundi, Kenya, Rwanda, Nigeria, and Uganda, prompting urgent public health responses across the continent. Healthcare professionals emphasize that mpox can be transmitted through close contact with an infected individual, sexual activity, or inhalation of infectious particles. The virus typically replicates in the lymph nodes, leading to symptoms such as swelling and the emergence of rashes or lesions.
As the global community continues to navigate health challenges, coordination and collaboration become essential in combating infectious diseases like mpox, particularly in regions with existing healthcare infrastructure challenges. The vigilance of health authorities and community awareness will play a pivotal role in managing current and future health risks associated with this disease.
#HealthNews #MiddleEastNews
